Microcytosis in agnogenic myeloid metaplasia: Prevalence and clinical correlates

被引:7
|
作者
Tefferi, A
Dingli, D
Li, CY
Mesa, RA
机构
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
[2] Mayo Clin, Div Hematopatol, Rochester, MN 55905 USA
关键词
myelofibrosis; microcytosis; prognosis; incidence; survival;
D O I
10.1016/j.leukres.2005.10.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Microcytosis is a characteristic laboratory feature for both iron deficiency anemia and thalassemia. It is also infrequently seen in "anemia of chronic disease" that accompanies a spectrum of chronic conditions including rheumatoid arthritis, polymyalgia rheumatica, diabetes mellitus, connective tissue disease, and protracted infection. In addition, there is a well established but pathogenetically obscure association of microcytosis with Hodgkin's lymphoma, Castleman's disease, and renal cell carcinoma. In the current study, we show that microcytosis is a frequent laboratory feature in agnogenic myeloid metaplasia and investigate its clinical relevance in the particular setting., (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:677 / 680
页数:4
相关论文
共 50 条
  • [41] Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia
    Petroianu, A
    INTERNATIONAL SURGERY, 1996, 81 (02) : 177 - 179
  • [42] POSTPOLYCYTHEMIA MYELOID METAPLASIA - EXPERIENCE WITH A LARGE COHORT OF PATIENTS
    RANDI, ML
    BARBONE, E
    FABRIS, F
    VAROTTO, L
    MACRI, C
    GIROLAMI, A
    JOURNAL OF MEDICINE, 1994, 25 (06) : 363 - 369
  • [43] POLYCYTHEMIA AFTER MYELOID METAPLASIA WITH FIBROSIS - AN UNUSUAL SEQUENCE
    GARDAIS, J
    SURANITI, S
    FRESSINAUD, P
    HAEMATOLOGICA, 1992, 77 (05) : 433 - 434
  • [44] Incidence, survival and prevalence of myeloid malignancies in Europe
    Visser, O.
    Trama, A.
    Maynadie, M.
    Stiller, C.
    Marcos-Gragera, R.
    De Angelis, R.
    Mallone, S.
    Tereanu, C.
    Allemani, C.
    Ricardi, U.
    Schouten, H. C.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (17) : 3257 - 3266
  • [45] Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasia
    Strasser-Weippl, Kathrin
    Steurer, Michael
    Kees, Mathias
    Augustin, Florian
    Tzankov, Alexandar
    Dirnhofer, Stephan
    Fiegl, Michael
    Simonitsch-Klupp, Ingrid
    Gisslinger, Heinz
    Zojer, Niklas
    Ludwig, Heinz
    CANCER, 2006, 107 (12) : 2801 - 2806
  • [46] Chronic Idiopathic Myelofibrosis with Myeloid Metaplasia Presenting as Refractory Ascites
    Patra, Bijoy
    Maheshwari, Anu
    Chandra, Jagdish
    Aneja, Satinder
    Agarwal, Shilpi
    Nangia, Anita
    Seth, Anju
    PEDIATRIC BLOOD & CANCER, 2010, 54 (01) : 151 - 153
  • [47] Pathogenesis of myelofibrosis with myeloid metaplasia: Insight from mouse models
    Chagraoui, Hedia
    Wendling, Francoise
    Vainchenker, William
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2006, 19 (03) : 399 - 412
  • [48] Dyspnea secondary to pulmonary hypertension in a patient with splenic myeloid metaplasia
    Haddad, F.
    Anouti, S.
    Maalouly, G.
    Jammal, M.
    Nemnoum, R.
    Kettaneh, A.
    REVUE DE MEDECINE INTERNE, 2009, 30 (09): : 803 - 805
  • [49] Myeloid metaplasia of the spleen: Splenectomy can be followed by hepatocellular failure
    Andres, E
    Grunenberger, F
    Maloisel, F
    Schlienger, JL
    Oberling, F
    Imler, M
    SEMAINE DES HOPITAUX, 1998, 74 (3-4): : 83 - 85
  • [50] HEMATOPOIETIC PROGENITOR CELLS IN A PATIENT WITH MYELOID METAPLASIA WITHOUT MYELOFIBROSIS
    KUBOTA, K
    TAMURA, J
    KURABAYASHI, H
    MURAKAMI, H
    NARUSE, T
    TSUCHIYA, J
    JOURNAL OF MEDICINE, 1992, 23 (02) : 149 - 153